Literature DB >> 6386853

Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli.

C A Dinarello, J V O'Connor, G LoPreste, R L Swift.   

Abstract

Human growth hormone is biosynthetically produced in recombinant strains of Escherichia coli as methionyl human growth hormone (met-hGH). When purified from the bacterial culture, met-hGH is biologically active in established assays for growth hormone. Therefore, a phase I trial of met-hGH was carried out in healthy human adults; during the first trial, however, signs, symptoms, and clinical laboratory tests characteristic of an acute-phase response to pyrogenic agents was observed. Prior testing of the met-hGH preparation used in the phase I trial did not reveal evidence of toxicity, and the U.S. Pharmacopeial Convention rabbit pyrogen test, as well as the Limulus amoebocyte lysate (LAL) test, had not detected significant levels of exogenous pyrogens or endotoxin. In addition, standard inhibition studies with added endotoxin showed no inhibition by the LAL test. When this preparation of met-hGH was incubated with human blood mononuclear cells, leukocytic pyrogen (LP) was released into the supernatant medium, suggesting that the preparation contained pyrogenic material. Various lots of met-hGH based on different purification and formulating methods were tested by the human LP assay for contaminating pyrogens. The results of these tests aided in the identification of procedures for met-hGH preparations which did not induce LP in vitro. Thus, subsequent lots of met-hGH which had passed the LP test were used in repeat clinical studies, and no inflammatory or pyrogenic reactions were observed. When the LP test was used, experiments revealed that the original lot of met-hGH was contaminated with endotoxin which had not been detected in the LAL or rabbit pyrogen tests. Lyophilization in glycine-phosphate buffer had resulted in a 10- to 20-fold reduction of endotoxin reactivity in the LAL test and the U.S. Pharmacopeial Convention rabbit pyrogen test. These data provide a probable explanation for the negative result from the LAL and rabbit pyrogen test in the initial lot of met-hGH which induced acute-phase reactions. In addition, these studies demonstrate that the release of LP from human cells is a reliable indicator of the presence of materials that are pyrogenic for humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386853      PMCID: PMC271322          DOI: 10.1128/jcm.20.3.323-329.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Further studies on the antipyretic action of polymyxin B in pyrogen-induced fever.

Authors:  A S van Miert; C T van Duin
Journal:  Arzneimittelforschung       Date:  1978

2.  Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins.

Authors:  R J Elin; S M Wolff
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

3.  Studies on the mechanism of endogenous pyrogen production. II. Role of cell products in the regulation of pyrogen release from blood leukocytes.

Authors:  P Bodel
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

4.  Factors affecting the quantitative production and assay of human leukocytic pyrogen.

Authors:  R K Root; J J Nordlund; S M Wolff
Journal:  J Lab Clin Med       Date:  1970-04

5.  Preliminary studies on the immunogenicity and amount of Escherichia coli polypeptides in biosynthetic human insulin produced by recombinant DNA technology.

Authors:  R S Baker; J R Schmidtke; J W Ross; W C Smith
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

6.  Effect of induced fever on serum iron and ferritin concentrations in man.

Authors:  R J Elin; S M Wolff; C A Finch
Journal:  Blood       Date:  1977-01       Impact factor: 22.113

7.  Purified human growth hormone from E. coli is biologically active.

Authors:  K C Olson; J Fenno; N Lin; R N Harkins; C Snider; W H Kohr; M J Ross; D Fodge; G Prender; N Stebbing
Journal:  Nature       Date:  1981-10-01       Impact factor: 49.962

Review 8.  Fever: pathogenesis, pathophysiology, and purpose.

Authors:  H A Bernheim; L H Block; E Atkins
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

Review 9.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

10.  Demonstration and characterization of two distinct human leukocytic pyrogens.

Authors:  C A Dinarello; N P Goldin; S M Wolff
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  8 in total

1.  Establishment of beta-hydroxy fatty acids as chemical marker molecules for bacterial endotoxin by gas chromatography-mass spectrometry.

Authors:  S K Maitra; R Nachum; F C Pearson
Journal:  Appl Environ Microbiol       Date:  1986-09       Impact factor: 4.792

2.  Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial cultures.

Authors:  C A Dinarello; G Lonnemann; R Maxwell; S Shaldon
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

3.  Evaluation of the in vitro pyrogen test system based on proinflammatory cytokine release from human monocytes: comparison with a human whole blood culture test system and with the rabbit pyrogen test.

Authors:  Yukari Nakagawa; Hideko Maeda; Toshimi Murai
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients.

Authors:  J W Mier; G Vachino; J W van der Meer; R P Numerof; S Adams; J G Cannon; H A Bernheim; M B Atkins; D R Parkinson; C A Dinarello
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

5.  In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations.

Authors:  J K Chia; E J McManus
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

6.  Analysis of IL-1 β release from cryopreserved pooled lymphocytes in response to lipopolysaccharide and lipoteichoic acid.

Authors:  Sreelekshmi R Nair; C S Geetha; P V Mohanan
Journal:  Biomed Res Int       Date:  2013-08-20       Impact factor: 3.411

7.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

8.  Use of Toll-like receptor assays for the detection of bacterial contaminations in icodextrin batches released for peritoneal dialysis.

Authors:  Hêla Hacine-Gherbi; Agnès Denys; Mathieu Carpentier; Arnaud Heysen; Pierrick Duflot; Pierre Lanos; Fabrice Allain
Journal:  Toxicol Rep       Date:  2017-10-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.